Therapy of tuberculosis
Abstract
Despite its great decline in recent years as a cause of death, tuberculosis remains a curable and preventable disease. Remarkable progress has been made in understanding the pathogenesis and management of both pulmonary and extrathoracic disease. With the availability of multiple bactericidal drugs the length of treatment has been considerably shortened, while maintaining the high cure rate and low relapse rate. With the transfer of the treatment from the sanitoriums and specialized hospitals to mainstream outpatient medicine, it is incumbent upon all physicians who treat tuberculous patients to understand the actions of each drug and the most effective combinations.
Similar articles
-
Diagnosis and management of tuberculosis.Prim Care. 1979 Mar;6(1):43-62. Prim Care. 1979. PMID: 111269 Review. No abstract available.
-
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.Mayo Clin Proc. 1983 Apr;58(4):233-40. Mayo Clin Proc. 1983. PMID: 6834890
-
[Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].Dtsch Med Wochenschr. 1970 Jan 16;95(3):139-41. Dtsch Med Wochenschr. 1970. PMID: 5411222 German. No abstract available.
-
Management of tuberculosis in elderly persons.Compr Ther. 1984 Jul;10(7):57-62. Compr Ther. 1984. PMID: 6540155 No abstract available.
-
The impact of chemotherapy on the care of patients with tuberculosis.Am Rev Respir Dis. 1974 Jun;109(6):636-64. doi: 10.1164/arrd.1974.109.6.636. Am Rev Respir Dis. 1974. PMID: 4209115 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical